Candesant Biomedical

Acquired

Nashville, United States · Founded 2015 · $44.1M raised

Employees
11–50
Founded
2015
Business Model
B2C
Total Funding
$44.1M
Last Round
$35.0M Series BJun 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Candesant Biomedical developed the Brella SweatControl Patch, an FDA-cleared treatment for primary axillary hyperhidrosis (excessive underarm sweating) in adults, built on the company's patented targeted alkali thermolysis (TAT) technology. Brella was created by Candesant Biomedical, headquartered in Nashville, TN. As of June 2025, the company was in the process of being sold, leaving no Brella sales representatives available and limiting access to the treatment.

Summary

Candesant Biomedical is a Biotech company based in Nashville, United States, founded in 2015. It has raised $44.1M in total across 2 rounds, most recently a $35.0M Series B round in Jun 2023. Investors include Polaris Partners, KCK MedTech and Correlation Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2023
$35.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Candesant Biomedical on Indexed.vc
<a href="https://indexed.vc/companies/candesant-biomedical"><img src="https://indexed.vc/api/badge/company/candesant-biomedical" alt="Candesant Biomedical on Indexed.vc" width="260" height="76" /></a>